Levosert
Phase 3- Indications
- Contraception, Heavy menstrual bleeding
Company intelligence / Profile preview
Uteron Pharma
LIEGE / Grâce-Hollogne, BELGIUMprnewswire.com ↗
- Ownership
- Private
- Employees
- ~60
- Development stage
- Phase 3
01
Overview
Uteron Pharma developed a strong pipeline focused on women’s health. Its lead product was Levosert—a hormonal IUD delivering levonorgestrel—pending EU approval and in late Phase III trials for the US. Other programs included next-generation oral contraceptives using estetrol and novel diagnostics to improve IVF outcomes. The company had a GMP-approved manufacturing facility supporting R&D and clinical supply[2][6]. No recent independent clinical results post-acquisition.
- Therapeutic areas
- Women's Health
- Modalities
- Hormonal intrauterine devices (IUDs)oral contraceptives with natural estrogenbiochemical diagnostic tests for IVF success ratespharmacologic treatments for cervical dysplasia
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Gedeon Richter (Eastern Europe marketing rights for Levosert)Medicines360 (US marketing rights)Pantarhei Bioscience co-development partnership on Estelle/oral contraceptive program
Beyond the preview
Go deeper on Uteron Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Uteron Pharma.